Skip To Main Content
Hirotoshi Watanabe on Muck Rack

Hirotoshi Watanabe

As seen in: JAMA: Journal of the American Medical Association, JAMA Cardiology, AHA/ASA Journals, Healio, Healio Cardiac/Vascular Intervention, JACC (Journal of the American College of Cardiology), RadcliffeCardiology.com, Journal of Interventional Radiology (JVIR), The European Heart Journal Podcast
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Hirotoshi

Contact Hirotoshi, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Aspirin vs Clopidogrel 1 Month After Acute Coronary Syndrome With High-Bleeding Risk or ST-Segment Elevation:

|
By Yuki Obayashi, Masahiro Natsuaki, Hirotoshi Watanabe, Takeshi Morimoto
| JACC (Journal of the American College of Cardiology)
JACC Journals › JACC: Interventions › Archives › Vol. 18 No. 17 : JACC: Cardiovascular Interventions Volume 18, Number 17 Get full access to this article View all available purchase options and get full access to this article. Supplementary Material Supplemental Material (mmc1.docx) References 1. Byrne R.A., Rossello X., Coughlan J.J., et al. 2023 ESC guidelines for the management of acute coronary syndromes. Eur Heart J. 2023;44:38: 3720-3826. 2. Lawton J.S., Tamis-Holland J.E., Bangalore S., et al.
Open in Who Shared Issue with article?

Aspirin vs. clopidogrel monotherapy after percutaneous coronary intervention: 1-year follow-up of the STOPDAPT-3 trial

|
By Hirotoshi Watanabe
| The European Heart Journal Podcast
Aspirin has been a commonly used and inexpensive antiplatelet drug and was the standard drug used as monotherapy following 1-month dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI) in the bare metal stent era and following prolonged DAPT in the early periods after introduction of drug-eluting stents (DES).1,2 Moreover, aspirin monotherapy was the regimen after DAPT cessation in the clinical trials exploring short (3–6 months) DAPT3–9 and in the clinical trials in...
Open in Who Shared Issue with article?

Comparison of Clopidogrel Monotherapy After 1 to 2 Months of Dual Antiplatelet Therapy With 12 Months of Dual Antiplatelet Therapy in Patients With Acute Coronary Syndrome: The STOPDAPT-2 ACS Randomized Clinical Trial | Acute Coronary Syndromes | JAMA Car

|
By Hirotoshi Watanabe, Takeshi Morimoto, Hyogo College, Masahiro Natsuaki
| JAMA Cardiology
Key Points Question Is 1 to 2 months of dual antiplatelet therapy (DAPT) followed by clopidogrel monotherapy noninferior to 12 months of DAPT with aspirin and clopidogrel for patients with acute coronary syndromes?
Open in Who Shared Issue with article?
See all 17 articles